US Stock MarketDetailed Quotes
ADGM Adagio Medical
- 1.101
- +0.130+13.42%
Trading Dec 26 14:13 ET
16.00MMarket Cap-0.40P/E (TTM)
1.200High1.040Low1.03MVolume1.130Open0.971Pre Close1.12MTurnover58.55%Turnover RatioLossP/E (Static)14.54MShares11.57052wk High0.21P/B1.94MFloat Cap0.95052wk Low--Dividend TTM1.76MShs Float12.380Historical High--Div YieldTTM16.49%Amplitude0.950Historical Low1.089Avg Price1Lot Size
Adagio Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -56.67%26K | 58.73%300K | 78K | 41K | 60K | -30.00%189K | 0 | 270K | |
| Operating revenue | ---- | -56.67%26K | 58.73%300K | --78K | --41K | --60K | -30.00%189K | --0 | --270K |
| Cost of revenue | 70.44%542K | 49.26%1.31M | 14.78%334K | 253K | 318K | -24.44%875K | 291K | 1.16M | |
| Gross profit | -100.00%-516K | -46.65%-1.01M | 12.03%-256K | -212K | -258K | 22.75%-686K | -291K | -888K | |
| Operating expense | 29.75%8.3M | 15.97%26.94M | -14.20%5.08M | 8.87M | 6.4M | 17.56%23.23M | 5.92M | 19.76M | |
| Selling and administrative expenses | ---- | 202.25%4.83M | 114.76%11.54M | 125.77%3.3M | --4.45M | --1.6M | 22.04%5.37M | --1.46M | --4.4M |
| Research and development costs | ---- | -27.70%3.47M | -13.76%15.4M | -60.17%1.77M | --4.42M | --4.8M | 16.28%17.86M | --4.45M | --15.36M |
| Operating profit | -32.48%-8.82M | -16.85%-27.94M | 14.09%-5.33M | -9.08M | -6.65M | -15.83%-23.91M | -6.21M | -20.65M | |
| Net non-operating interest income expense | -224.57%-753K | -1,589.80%-1.66M | -333.08%-576K | -483K | -232K | -3,366.67%-98K | -133K | 3K | |
| Non-operating interest income | ---- | 0.00%1K | -92.31%3K | -75.00%1K | --2K | --1K | 1,200.00%39K | --4K | --3K |
| Non-operating interest expense | ---- | 223.61%754K | 1,110.95%1.66M | 321.17%577K | --485K | --233K | --137K | --137K | --0 |
| Other net income (expense) | 164.85%1.55M | -2,628.99%-8.55M | -1,481.23%-4.27M | -1.2M | -2.39M | -51.99%338K | 309K | 704K | |
| Gain on sale of security | ---- | 166.54%1.59M | ---8.53M | ---4.36M | ---1.07M | ---2.39M | ---- | ---- | ---- |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --744K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---744K |
| Other non- operating income (expenses) | ---- | -1,175.00%-43K | -105.92%-20K | -69.90%93K | ---123K | --4K | 945.00%338K | --309K | ---40K |
| Income before tax | 13.56%-8.02M | -61.14%-38.15M | -68.72%-10.18M | -10.76M | -9.28M | -18.73%-23.67M | -6.03M | -19.94M | |
| Income tax | |||||||||
| Net income | 13.56%-8.02M | -61.14%-38.15M | -68.72%-10.18M | -10.76M | -9.28M | -18.73%-23.67M | -6.03M | -19.94M | |
| Net income continuous Operations | ---- | 13.56%-8.02M | -61.14%-38.15M | -68.72%-10.18M | ---10.76M | ---9.28M | -18.73%-23.67M | ---6.03M | ---19.94M |
| Minority interest income | |||||||||
| Net income attributable to the parent company | 13.56%-8.02M | -61.14%-38.15M | -68.72%-10.18M | -10.76M | -9.28M | -18.73%-23.67M | -6.03M | -19.94M | |
| Preferred stock dividends | |||||||||
| Other preferred stock dividends | |||||||||
| Net income attributable to common stockholders | 13.56%-8.02M | -61.14%-38.15M | -68.72%-10.18M | -10.76M | -9.28M | -18.73%-23.67M | -6.03M | -19.94M | |
| Basic earnings per share | 13.56%-0.5989 | -61.14%-2.8493 | -68.72%-0.7602 | -0.8038 | -0.6929 | -18.73%-1.7683 | -0.4506 | -1.4893 | |
| Diluted earnings per share | 13.56%-0.5989 | -61.14%-2.8493 | -68.72%-0.7602 | -0.8038 | -0.6929 | -18.73%-1.7683 | -0.4506 | -1.4893 | |
| Dividend per share | |||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | Unqualified Opinion with Explanatory Notes |
Heat List
US
Overall
Symbol
Price
% Chg
No Data